Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 170
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
MindMed Announces Positive Results from Collaborators’ Placebo-Controlled Investigator-Initiated Trial Published in...
Small Pharma to Participate in Upcoming September Investor Conferences
Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History
Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of...
Psyence Group Announces Amendment and Closing of Previously Announced Private Placement
atai Life Sciences to Participate in September Investor Events
Mindset Pharma Files National Patents Protecting Family 1 Application in 16...
Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida...
BetterLife and Collaborators to Submit Key Joint Research Publication
MindMed to Participate in H.C. Wainwright Global Investment ConferenceUSA – EnglishUSA...
Load more